With an ecosystem of high-throughput instruments generating multi-terabyte datasets, the data management capacity of a leading global gene therapy innovator had reached breaking point. It was too slow ...
Telix reported FY2025 revenue of $804M, up 56% YoY, with Precision Portfolio products Illuccix and Gozellix contributing $622M. Read why TLX stock is a Buy.
Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole ...
Rare Disease Day is held on the last day of February to raise awareness for rare diseases and address drug development ...
How innovative technologies like AI and gene editing are advancing rare disease drug discovery and development.
A blockbuster drug is a best-selling medication earning over $1 billion annually. Learn about them and how they revolutionize ...
New FDA guidelines for personalized genomic drug development are a step forward in advancing new therapies for ultrarare diseases, but industry leaders need further clarification.
In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.
SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
Creating a drug that might help treat or cure a health condition in humans is a long, complex process. After developing a ...
Psychedelic drug development can still benefit from the FDA Commissioner’s National Priority Review Voucher Pilot Program, though the CNPV designation was not given to Compass Pathways’ synthetic ...
The FDA guidelines aim to create a new pathway for bespoke therapies due to the challenges of conducting large studies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results